Pacira BioSciences Inc. (PCRX)
NASDAQ: PCRX
· Real-Time Price · USD
24.75
-0.24 (-0.96%)
At close: Aug 15, 2025, 3:59 PM
24.78
0.12%
After-hours: Aug 15, 2025, 04:54 PM EDT
Pacira BioSciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -127.46M | -103.73M | -99.56M | -90.73M | 63.59M | 70.47M | 41.95M | 6.98M | -4.57M | -10.46M | 15.91M | 20.88M | 39.23M | 38.44M | 41.98M | 61.63M | 174.08M | 147.73M |
Depreciation & Amortization | 89.99M | 81.53M | 78.78M | 76.03M | 74.21M | 74.4M | 75.57M | 87.5M | 89.26M | 91.07M | 91.5M | 74.17M | 59.7M | 43.73M | 28.55M | 20.54M | 19.85M | 19.94M |
Stock-Based Compensation | 55.52M | 52.57M | 51.17M | 51.33M | 50.63M | 49.06M | 47.9M | 48.15M | 48.3M | 48.89M | 48.09M | 46.3M | 44.41M | 43.33M | 42.25M | 42.25M | 42.42M | 41.18M |
Other Working Capital | 2M | -3.66M | 1.26M | 1.06M | 2.88M | -1.02M | -15.53M | -16.99M | -20.46M | -20.67M | -23.11M | 1.11M | 4.75M | 12.61M | 6.49M | -8.82M | -3.03M | 868K |
Other Non-Cash Items | 137.76M | 208.34M | 258.49M | 254.94M | 94.33M | 31.72M | 19.39M | 40.64M | 45.36M | 43.44M | 14.15M | -1.25M | -6.49M | 16.26M | 20.75M | 152.75M | 159.47M | 152.67M |
Deferred Income Tax | 6.77M | 18.55M | 20.62M | 23.71M | 27.51M | 26.42M | 15.62M | -1.83M | -6.04M | -15.32M | -7.95M | 814K | 5.45M | 9.15M | 10.87M | -113.66M | -243.57M | -253.42M |
Change in Working Capital | -28.06M | -31.22M | -24.33M | -15.65M | -20.12M | -21.95M | -45.78M | -32.34M | -25M | -24.01M | -16.43M | -14.46M | 1.79M | -6.5M | -18.67M | -14.34M | -23.59M | -25.2M |
Operating Cash Flow | 134.52M | 175.75M | 189.39M | 203.84M | 194.36M | 184.62M | 154.65M | 149.1M | 147.32M | 133.63M | 145.27M | 126.45M | 144.09M | 144.41M | 125.72M | 149.17M | 128.66M | 82.91M |
Capital Expenditures | -17.45M | -16.35M | -10.64M | -10.32M | -9.62M | -11.43M | -15.16M | -18.86M | -20.64M | -28.97M | -30.08M | -33.75M | -41.65M | -40.46M | -45.87M | -51.11M | -45.8M | -44.15M |
Cash Acquisitions | -16.7M | -16.7M | n/a | -10.17M | -9.22M | -19.95M | -92.7M | -69.78M | -28.39M | -17.66M | 42.34M | -390.46M | -435.76M | -444.82M | -430.85M | -11.96M | -9M | 60K |
Purchase of Investments | -222.37M | -265.79M | -252.21M | -232.94M | -173.88M | -146.92M | -144.37M | -186.7M | -276.56M | -298.58M | -400.69M | -430.42M | -493.75M | -579.22M | -611.49M | -733.34M | -792.38M | -661.78M |
Sales Maturities Of Investments | 240.53M | 205.46M | 179.57M | 168.72M | 156.78M | 154.18M | 237.07M | 285.91M | 334.38M | 363.82M | 237.58M | 750.76M | 837.38M | 932.51M | 1.08B | 632.77M | 515.76M | 402.38M |
Other Investing Acitivies | n/a | -13.63M | -26.32M | -16.15M | -17.09M | 7.26M | 92.7M | 69.78M | 28.39M | 30.41M | -74.33M | -65.58M | -45.25M | -63.16M | -32.38M | -96.29M | -269.38M | -219.18M |
Investing Cash Flow | -16M | -93.38M | -83.28M | -74.53M | -26.71M | -4.17M | 77.54M | 80.36M | 37.18M | 49.02M | -225.19M | -169.46M | -157.02M | -173.15M | -20.79M | -170.03M | -337.8M | -304.7M |
Debt Repayment | -8.44M | 76.61M | 76.61M | 76.61M | 51.62M | -36.25M | -180.76M | -237.32M | -218.89M | -382.41M | -427.69M | -9.12M | 260K | 166.59M | 359.2M | n/a | 192.62M | 192.62M |
Common Stock Repurchased | 25M | 4K | n/a | -106K | -25.11M | -110K | -106K | 2.95M | 2.95M | 2.95M | 2.95M | n/a | n/a | n/a | n/a | 166.28M | 133.19M | 133.19M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.67M | -2.67M | -2.67M | -2.67M | -1.62M | -1.62M | -1.62M |
Other Financial Acitivies | -53.11M | -59.43M | -59.25M | -59.08M | -59.02M | 4.31M | -2.6M | -2.77M | -1.2M | 8.23M | 26.17M | 21.48M | 22.93M | 16.16M | 15.46M | 29.65M | 43.74M | 41.29M |
Financial Cash Flow | -65.3M | 17.19M | 17.36M | 17.54M | -7.4M | -31.94M | -183.03M | -239.76M | -219.75M | -373.85M | -401.53M | 18.39M | 29.22M | 188.78M | 380.69M | 29.65M | 236.35M | 233.91M |
Net Cash Flow | 53.43M | 99.56M | 123.48M | 146.85M | 160.24M | 148.51M | 49.16M | -10.3M | -35.25M | -191.21M | -481.44M | -24.61M | 16.29M | 160.05M | 485.62M | 8.79M | 27.22M | 12.11M |
Free Cash Flow | 117.07M | 159.4M | 178.75M | 193.53M | 184.74M | 173.19M | 139.49M | 130.25M | 126.68M | 104.65M | 115.2M | 92.7M | 102.44M | 103.95M | 79.85M | 98.06M | 82.87M | 38.76M |